Key result
A heart failure telemonitoring program was associated with a 50% decrease in heart failure-related hospitalizations at 6 months compared to the 6 months before enrollment (IRR 0.50; P<.001).
Why the study?
Telemonitoring can improve HF outcomes, but the 6-month impact of implementing the Medly telemonitoring program as standard of care on health service utilization, clinical outcomes, QoL, and self-care required evaluation.
Does a mobile phone-based telemonitoring program reduce HF-related hospitalizations in outpatient heart failure patients?
Observational (n=315)
No
Does a mobile phone-based telemonitoring program reduce HF-related hospitalizations in outpatient heart failure patients?
Relative Risk: 0.5
p-value: p=<.001
A pragmatic heart failure telemonitoring program implemented as standard of care significantly reduced HF-related hospitalizations and improved quality of life and self-care.
Should not yet change HF telemonitoring practice; leaves open need for randomized confirmation.
BACKGROUND Telemonitoring (TM) can improve heart failure (HF) outcomes by facilitating patient self-care and clinical decisions. The Medly program enables patients to use a mobile phone to record daily HF readings and receive personalized self-care messages generated by a clinically validated algorithm. The TM system also generates alerts, which are immediately acted upon by the patients’ existing care team. This program has been operating for 3 years as part of the standard of care in an outpatient heart function clinic in Toronto, Canada. OBJECTIVE This study aimed to evaluate the 6-month impact of this TM program on health service utilization, clinical outcomes, quality of life (QoL), and patient self-care. METHODS This pragmatic quality improvement study employed a pretest-posttest design to compare 6-month outcome measures with those at program enrollment. The primary outcome was the number of HF-related hospitalizations. Secondary outcomes included all-cause hospitalizations, emergency department visits (HF related and all cause), length of stay (HF related and all cause), and visits to the outpatient clinic. Clinical outcomes included bloodwork (B-type natriuretic peptide [BNP], creatinine, and sodium), left ventricular ejection fraction, and predicted survival score using the Seattle Heart Failure Model. QoL was measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ) and the 5-level EuroQol 5-dimensional questionnaire. Self-care was measured using the Self-Care of Heart Failure Index (SCHFI). The difference in outcome scores was analyzed using negative binomial distribution and Poisson regressions for the health service utilization outcomes and linear regressions for all other outcomes to control for key demographic and clinical variables. RESULTS Available data for 315 patients enrolled in the TM program between August 2016 and January 2019 were analyzed. A 50% decrease in HF-related hospitalizations (incidence rate ratio [IRR]=0.50; P<.001) and a 24% decrease in the number of all-cause hospitalizations (IRR=0.76; P=.02) were found when comparing the number of events 6 months after program enrollment with the number of events 6 months before enrollment. With regard to clinical outcomes at 6 months, a 59% decrease in BNP values was found after adjusting for control variables. Moreover, 6-month MLHFQ total scores were 9.8 points lower than baseline scores (P<.001), representing a clinically meaningful improvement in HF-related QoL. Similarly, the MLHFQ physical and emotional subscales showed a decrease of 5.4 points (P<.001) and 1.5 points (P=.04), respectively. Finally, patient self-care after 6 months improved as demonstrated by a 7.8-point (P<.001) and 8.5-point (P=.01) increase in the SCHFI maintenance and management scores, respectively. No significant changes were observed in the remaining secondary outcomes. CONCLUSIONS This study suggests that an HF TM program, which provides patients with self-care support and active monitoring by their existing care team, can reduce health service utilization and improve clinical, QoL, and patient self-care outcomes.
No takes yet. Share an insight, caveat, or question.
Ware et al. (2019) conducted an observational in Heart failure (n=315). Medly telemonitoring program vs. 6 months before enrollment was evaluated on Number of HF-related hospitalizations (IRR 0.50, p=<.001). A heart failure telemonitoring program was associated with a 50% decrease in heart failure-related hospitalizations at 6 months compared to the 6 months before enrollment (IRR 0.50; P<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: